Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management strategies for severe Pseudomonas aeruginosa infections
Hermann Do Rego, Jean‐François Timsit
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 6, pp. 585-595
Closed Access | Times Cited: 9

Showing 9 citing articles:

Impact of Multiplex PCR in the Therapeutic Management of Severe Bacterial Pneumonia
Julien Dessajan, Jean‐François Timsit
Antibiotics (2024) Vol. 13, Iss. 1, pp. 95-95
Open Access | Times Cited: 13
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso, Arianna Granese, Barbara De Filippis
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 6, pp. 493-509
Closed Access | Times Cited: 4
Genomic profiling and molecular dynamics analysis of parDE Pa toxin-antitoxin homologs targeting DNA gyrase in Pseudomonas aeruginosa : insights from computational investigations
Nomita Gupta, Mohit Yadav, Waseem Ali, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-17
Closed Access
Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal
Pablo Vidal, Sandra Campos-Fernández, Elena Cuenca-Fito, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 178-178
Open Access
Combating Metallo-β-Lactamase-Producing Pseudomonas aeruginosa: The Fractional Inhibitory Concentration Index as a Tool to Evaluate Antibiotic Synergy
Guido Granata, Carolina Venditti, Claudia Rotondo, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 210-210
Open Access
Past, present and future perspectives on aztreonam and Avibactam
Karen Bush
Expert Review of Anti-infective Therapy (2025), pp. 1-14
Closed Access
Development and Characterization of LasR Immobilized Monolithic Column for Screening Active Ingredients as Quorum Sensing Inhibitors Against P. aeruginosa in Natural Products
Zheng Liu, Yue Yang, Xiaoyuan Xie, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2051-2064
Open Access
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Aerobic vaginitis in women seen at the laboratory of the university hospital of Befelatanana, Antananarivo, Madagascar
Zafindrasoa Domoina Rakotovao-Ravahatra, Ianja Razanadrakoto, Solofo Sarah Rafaramalala, et al.
African Journal of Clinical and Experimental Microbiology (2024) Vol. 25, Iss. 2
Open Access
Recombinase-aided amplification assay for rapid detection of imipenem-resistant Pseudomonas aeruginosa and rifampin-resistant Pseudomonas aeruginosa
Yao Zhou, Ruiqing Shi, Liang Mu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Page 1

Scroll to top